Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Algeta Awarded Grant for Thorium-based Drug Development

June 22, 2011 11:46 am | News | Comments

Algeta announced it has been awarded a $1.9 million grant from the Research Council of Norway to develop targeted thorium conjugates (TTCs), novel tumor-targeted alpha-pharmaceuticals based on thorium-227.


Novartis: Panel Votes Against Arthritis Drug

June 22, 2011 11:41 am | News | Comments

Novartis said an advisory panel recommended against approving a potential treatment for the inflammatory disease gouty arthritis because they were concerned about the drug's safety.


Naurex Inititates Phase 2 Trial of GLYX-13

June 22, 2011 11:35 am | News | Comments

Naurex Inc. has initiated a Phase 2 clinical trial of its lead compound GLYX-13.


Orbital Shaker

June 22, 2011 7:24 am | Product Releases | Comments

Because automation is highly desired by researchers, LabStrong Corporation has added their automated AccuStop technology to their revolutionary Helix 250 Orbital Shaker.


Peristaltic Pump

June 22, 2011 7:21 am | Product Releases | Comments

INTEGRA has released a new application note that demonstrates how combining its MEDIAJET Petri dish filler with the DOSE IT peristaltic pump provides an optimised automated solution for the production of high quality blood agar.


CiToxLAB Announces Its Official Launch

June 22, 2011 7:12 am | News | Comments

CiToxLAB, created through the merger of CIT and LAB Research, provides a comprehensive range of pre-clinical and specialty services from four facilities in France, Canada, Denmark, and Hungary.


Treating Acute Radiation Sickness with Mesenchymal Stromal Stem Cells

June 22, 2011 7:06 am | by William R. Prather RPh, MD, Senior VP Corporate Development; Pluristem Therapeutics, Haifa, Israel | Articles | Comments

The recent nuclear crisis in Japan has highlighted the urgent need to develop products for the treatment of acute radiation sickness and radiation exposure.


Lyrica Does Well in New Pain Study

June 22, 2011 6:42 am | News | Comments

Drugmaker Pfizer Inc. said that early results from a late-stage study of its pain treatment Lyrica showed that it did better than a placebo in reducing one type of pain after a spinal cord injury.


FDA Sends CSL Warning Letter

June 22, 2011 6:37 am | News | Comments

The Food and Drug Administration has issued a warning letter to CSL Biotherapies over its manufacturing facilities for the influenza vaccine, Afluria, which it sells in the US.


Abbott Paying Biotest $85M for Collaboration

June 22, 2011 6:27 am | News | Comments

Abbott Laboratories said that it will pay German company Biotest AG $85 million upfront and royalty and milestone payments that could total $395 million as part of a collaboration over a potential rheumatoid arthritis and psoriasis treatment.


AstraZeneca In $1.8B Dental Deal

June 22, 2011 6:22 am | News | Comments

AstraZeneca PLC is selling its Astra Tech dental business, the world's third-largest maker of dental implants, for $1.8 billion, the Anglo-Swedish pharmaceutical company announced.


Advisory Panel Concerned About Gout Drug

June 22, 2011 6:20 am | News | Comments

Novartis AG said an advisory panel recommended against approving a potential treatment for the inflammatory disease gouty arthritis because they were concerned about the drug's safety.


FDA Unveils Safety Strategy for Imported Products

June 21, 2011 12:02 pm | News | Comments

The U.S. Food and Drug Administration (FDA) has unveiled a strategy to meet the challenges posed by imports of FDA-regulated products and a complex global supply chain.


Phase III Results of LCP-TacroTM Trial

June 21, 2011 11:56 am | News | Comments

LifeCycle Pharma reported the company’s lead product candidate, LCP-Tacro, successfully demonstrated non-inferiority compared to tacrolimus (Prograf from Astellas Pharma) in its Phase III trial, Study 3001.


FDA Aims to Improve Understanding of Drug Ads

June 21, 2011 11:48 am | News | Comments

Findings from three studies conducted by the U.S. Food and Drug Administration (FDA) confirm that the way information is conveyed and displayed in printed drug advertising affects consumer understanding of prescription medications.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.